Stocksigma LogoStocksigma Logo

Sudarshan Pharma Terminates Acquisition of Med Therapy Biotechnology Common Stock

Sudarshan Pharma Industries announced on 7th Oct'26 that its proposal to acquire a 9.50% equity stake in USA-based Med Therapy Biotechnology Inc

Sudarshan Pharma Terminates Acquisition of Med Therapy Biotechnology Common Stock

Sudarshan Pharma Industries Ltd 路 Others (Uncategorized) 路 07 Oct 2026, 8:05 pm

Sudarshan Pharma Terminates Acquisition of Med Therapy Biotechnology Common Stock Sudarshan Pharma Industries announced on 7th Oct'26 that its proposal to acquire a 9.50% equity stake in USA-based Med Therapy Biotechnology Inc. has been terminated. Concurrently, the proposals for promoters Hemal Mehta (Chairman & Managing Director) and Sachin Mehta (Joint Managing Director) to acquire a 1.50% equity stake each in Med Therapy Biotechnology have also been terminated.

Original exchange filing (PDF)

More announcements from Sudarshan Pharma Industries Ltd

All Sudarshan Pharma Industries Ltd announcements